The Devastating Impact of the Cancer-Drug Shortage in the U.S.
TL;DR Summary
A factory in India that produced a widely used generic chemotherapy drug called cisplatin has been suspended due to quality assurance issues, triggering a shortage of the drug in the US. The shortage has affected hundreds of thousands of cancer patients, who are now scrambling to procure supplies or come up with alternative treatments. The fragile supply chain for generic drugs, which make up more than 90% of prescriptions in the US, is vulnerable to disruption at a single plant, putting new focus on the dicey business of making generic drugs.
- Behind cancer-drug shortage in U.S., a fragile supply of generic drugs The Washington Post
- Cancer patient concerned about critical drug shortage, 'it's depressing and distressing' News4JAX The Local Station
- Doctors told a vocal cord cancer patient he had an 88% chance of a cure with treatment. But because of a cancer drug shortage, that may drop to 45%. Yahoo Life
- The Cancer-Drug Shortage Is a Disaster The Atlantic
- Nashville cancer patients worried as FDA addresses chemotherapy drug shortage in U.S. WKRN News 2
Reading Insights
Total Reads
0
Unique Readers
12
Time Saved
9 min
vs 10 min read
Condensed
95%
1,802 → 91 words
Want the full story? Read the original article
Read on The Washington Post